Publikationen in Zusammenarbeit mit Forschern von Clínica Universitaria de Navarra (85)

2022

  1. Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies

    Frontiers in Neurology, Vol. 13

  2. Long-Term Outcome of Critically Ill Advanced Cancer Patients Managed in an Intermediate Care Unit

    Journal of Clinical Medicine, Vol. 11, Núm. 12, pp. 3472

2021

  1. Acquiring sepsis competencies through simulation-based learning bundle during intermediate care unit internship

    Medicine, Vol. 100, Núm. 5, pp. e24483

  2. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?

    Journal of Internal Medicine, Vol. 289, Núm. 1, pp. 116-120

  3. Web-based formative assessment through clinical cases: role in pathophysiology teaching

    BMC Medical Education, Vol. 21, Núm. 1

2020

  1. Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: Preliminary experience from a series of 10 Spanish patients

    Thorax, Vol. 75, Núm. 12, pp. 1116-1118

2019

  1. Ultrasound/elastography techniques, lipidomic and blood markers compared to magnetic resonance imaging in non-alcoholic fatty liver disease adults

    International Journal of Medical Sciences, Vol. 16, Núm. 1, pp. 75-83

2017

  1. Conversion from calcineurin Inhibitor-Based immunosuppression to mycophenolate mofetil in monotherapy reduces risk of de novo malignancies after liver transplantation

    Annals of Transplantation, Vol. 22, pp. 141-147

2016

  1. Insulin-like growth factor I (IGF-I) expressed from an AAV1 vector leads to a complete reversion of liver cirrhosis in rats

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Design and performance of a new severity score for intermediate care

    PLoS ONE, Vol. 10, Núm. 6

2013

  1. Lung cancer screening with low-radiation dose computed tomography after liver transplantation

    Annals of Transplantation, Vol. 18, Núm. 1, pp. 587-592

  2. Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure

    PLoS ONE, Vol. 8, Núm. 1

2012

  1. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma

    European Journal of Surgical Oncology, Vol. 38, Núm. 7, pp. 594-601

2011

  1. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages

    Annals of Surgical Oncology, Vol. 18, Núm. 7, pp. 1964-1971

  2. Reply

    Liver Transplantation

  3. Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: The effect of smoking withdrawal

    Liver Transplantation, Vol. 17, Núm. 4, pp. 402-408

  4. Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells

    Journal of Hepatology, Vol. 55, Núm. 4, pp. 828-837

2010

  1. A phase i clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma

    Cancer Gene Therapy, Vol. 17, Núm. 12, pp. 837-843

  2. Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma

    International Journal of Radiation Oncology Biology Physics, Vol. 77, Núm. 5, pp. 1441-1448

  3. Hospitalismo: una disciplina en alza

    Gastroenterologia y Hepatologia Continuada, Vol. 9, Núm. 4, pp. 197-201